Immunitybio Inc is trading 4.5% up at $7.23 as it recovers from last week’s macro-driven selloff in alignment with a broader market rebound.
- The upward move follows a climb in the S&P 500 and Nasdaq, driven by improved investor sentiment and geopolitical de-escalation.
- With no company-specific news or filings reported on June 8, the stock is effectively bouncing within its recent trading range after facing macro pressure on Friday.